EGFR overexpression has been extensively studied due to its involvement in the development of lethal cancers, including non-small-cell lung cancer (NSCLC), and head-and-neck, breast, colon, and ovarian cancer [16,17]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.